Skip to content
Review Open access

Wearable Devices in Cardiovascular Care: A Narrative Review of the Transition Toward Predictive, Preventive, Personalized, and Participatory Medicine

Sep 2026 · Healthcare · Vol 14, pp. 2894 · 0 citations · 94 references
Medicine

TL;DR

This narrative review synthesizes the contemporary evidence base for wearable cardiovascular technology and organizes it around the four pillars of P4 medicine, with the explicit aim of distinguishing what is clinically proven from what remains aspirational.

Abstract

Cardiovascular diseases remain the leading cause of global mortality, yet conventional diagnostics are episodic and clinic-centered, missing the dynamic physiological events that unfold between encounters. Wearable devices offer continuous, real-world monitoring and, together with artificial intelligence, digital biomarkers, and telecardiology, increasingly support a shift toward predictive, preventive, personalized, and participatory (P4) cardiovascular care. This narrative review synthesizes the contemporary evidence base for wearable cardiovascular technology and organizes it around the four pillars of P4 medicine, with the explicit aim of distinguishing what is clinically proven from what remains aspirational. The wearable ecosystem now spans consumer smartwatches, medical-grade ECG patches, smart textiles, and emerging soft bioelectronics, generating an expanding repertoire of digital biomarkers. Evidence is strongest where validation is most mature: atrial fibrillation screening, supported by large-scale studies, and structured heart-failure telemonitoring, associated with reductions in heart-failure hospitalization of 18–32% in structured programs. For acute coronary syndrome triage, cuffless blood pressure, cardiac rehabilitation, and AI-derived prognostic markers, the supporting evidence is growing but rests largely on analytical and early clinical validation rather than on demonstrated improvements in hard cardiovascular outcomes. Across all four pillars, translation is constrained by accuracy variability across demographic subgroups, regulatory fragmentation, data privacy concerns, interoperability deficits, and inequitable access for elderly, low-income, and low- and middle-income populations. Realizing the P4 promise will require harmonized validation standards, demographic-stratified accuracy reporting, equitable access strategies, and a clinical infrastructure capable of converting continuous wearable data into actionable decisions.

Read PDF

Similar papers

Review Oct 2026

Wearable Sensors and Remote Patient Monitoring in Cardiovascular Disease: From Continuous Physiological Surveillance to Actionable Insights.

This review examines the evolving role of wearable technologies across a 3-stage framework of cardiovascular care: surveillance, diagnosis, and intervention, and highlights major technological trends, including the diversification of sensing modalities, the growing integration of artificial intelligence, and the transi...

A. Tariq, Wonbum Sohn, Yoon Jae Lee et al. · 0 citations
Review Open access Jan 2026

Personalized Cardiac Rehabilitation: Integrating Biomarker‐Guided, Technology‐Enabled, and Population‐Specific Strategies in Exercise Medicine

Cardiovascular diseases remain the leading global cause of mortality and morbidity, necessitating continuous advancement in secondary prevention strategies. Cardiac rehabilitation (CR), a cornerstone of comprehensive cardiovascular care, has been significantly enhanced by innovations in exercise medicine, evolving towa...

Tong Liu, Yu-Ting Xia, Li Wei · 0 citations
Review Open access Oct 2026

AI-Powered Wearable Devices for Predictive Monitoring and Early Intervention in Chronic Diseases

Wearable medical devices integrated with artificial intelligence (AI) are transforming chronic disease management by enabling real-time health monitoring. Despite advances, gaps remain in predictive analytics and seamless integration into clinical workflows. This review addresses these challenges by evaluating AI-drive...

S. Ranga · 0 citations
Review Open access Sep 2026

From wrist to heart: clinical validation and real-world translation of wearable and portable AI-enhanced electrocardiography

Establishing clinical value will determine the role of wearable and portable AI-ECG in routine cardiovascular care, and whether AI-ECG changes management without increasing unnecessary investigation or workload.

A. El-Medany, A. Birdi, Aron Abraham et al. · 0 citations
Sep 2026

Personalized Multimodal Wearable-AI for Early Prediction of Heart Failure Decompensation Using Physiological Drift and Clinical Context

Heart failure (HF) is a progressive cardiovascular syndrome characterized by episodes of clinical stability. It interspersed with periods of worsening cardiac function and decompensation, often leading to emergency hospitalization, decreased quality of life, and increased mortality. Traditional monitoring relies heavil...

Bhawana Pillai · 0 citations
Review Open access Oct 2026

WEARABLE BIOSENSORS IN REMOTE CHRONIC DISEASE MONITORING: A STRUCTURED REVIEW OF IMPLEMENTATION BARRIERS AND HEALTH EQUITY IMPLICATIONS

This analysis targeted data documenting the logistical friction, long-term adherence failures, and unequal access surrounding continuous glucose monitors, ambulatory cardiac patches, and multi-parameter tracking devices.

Jakub Juskowiak, Z. Komin, Maryan Liasota et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.